The influence of low molecular weight heparin medication on plasma DNA in pregnant women

Prenat Diagn. 2015 Nov;35(11):1155-7. doi: 10.1002/pd.4668. Epub 2015 Sep 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / therapeutic use*
  • Blood Specimen Collection / methods*
  • Chromosome Disorders / diagnosis*
  • Chromosomes, Human, Pair 13
  • Chromosomes, Human, Pair 18
  • Cytosine
  • DNA / blood*
  • Diagnostic Errors / prevention & control*
  • Down Syndrome / diagnosis*
  • False Positive Reactions
  • Female
  • Guanosine
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Plasma
  • Pregnancy
  • Prenatal Diagnosis
  • Time Factors
  • Trisomy / diagnosis*
  • Trisomy 13 Syndrome
  • Trisomy 18 Syndrome

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Guanosine
  • Cytosine
  • DNA